文献速递围术期管理与 ERAS

合成封合止血贴片在腹腔镜肾部分切除术中替代肾实质缝合的通用性与临床效果

Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy.
PubMed 文献 · Surg Endosc · 2021-02-16

本研究回顾性比较了40例使用Veriset™止血贴片与40例传统缝合技术行腹腔镜肾部分切除术的患者。提示该贴片可作为肾实质缝合的替代选择。

要点

  • Veriset™贴片组手术时间和热缺血时间均显著低于传统缝合组。
  • 两组切缘阳性率及30天、90天并发症发生率无显著差异。
  • Veriset™组 trifecta 达标率65%,缝合组57.5%。

核心结论

  • Veriset™止血贴片可成功应用于腹腔镜肾部分切除术,操作便利,能缩短手术时间和热缺血时间,可能成为肾实质缝合的替代方案。

研究设计与样本

  • 回顾性研究,纳入孤立性恶性肾肿块疑似肾癌患者,Veriset™贴片组40例,传统缝合组40例,记录患者特征、手术时间、热缺血时间、术后病程及并发症,肿瘤复杂性按R.E.N.A.L.评分计算,结局按trifecta标准判定。

主要发现

  • 两组临床参数和中位R.E.N.A.L.评分(6)无显著差异。
  • Veriset™组平均热缺血时间14.6 min,缝合组20.6 min(p=0.01)。
  • 两组手术切缘无差异(p=0.602),术后30天(p=0.599)和90天(p=0.611)总体并发症率无差异。
  • Veriset™组trifecta达标率65%,缝合组57.5%。

关键数值与推荐

  • trifecta标准:切缘阴性、热缺血时间<25 min、30天内无并发症。

临床怎么用

  • 在腹腔镜肾部分切除术中,可考虑使用Veriset™止血贴片替代肾实质缝合,以缩短手术时间和热缺血时间。

局限性

  • 回顾性研究设计,样本量较小(每组40例),结论需进一步前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Improvements in laparoscopic partial nephrectomy (LPN) in order to minimize perioperative warm ischemia time (WIT), complications, and consequently patient outcome are desirable. Veriset™ is a ready-to-use hemostatic patch of absorbable oxidized cellulose and hydrogel components that has earlier been implemented in vascular and hepatic surgery. We report our experience using this device in LPN. METHODS: Patients with a solitary malignant renal mass suspicious for renal cancer underwent LPN with either the use of Veriset™ hemostatic patch (n = 40) or conventional suture technique (n = 40). Patient characteristics, operation time and WIT, postoperative course and complications were recorded retrospectively. Tumor complexity was calculated according to the R.E.N.A.L. score. Outcome was determined according to the "trifecta" criteria (negative surgical margin, WIT < 25 min, no complications within 30 days). RESULTS: No significant differences with regard to clinical parameters and median R.E.N.A.L. score (6) were observed between both groups. Operation time (mean 127.1 min vs. 162. 8 min; p = 0.001) and WIT were both lower in the Veriset™ group (14.6 min vs. 20.6 min; p = 0.01). No differences in surgical margins (p = 0.602) and overall complication rates at 30 (p = 0.599) and 90 days (p = 0.611) postoperatively were noticed. The surgical outcome according to "trifecta" was achieved in 65% of patients using Veriset™ and in 57.5% of patients by suture closure, respectively. CONCLUSION: The hemostatic Veriset™ patch can successfully be implemented in LPN. Handling and application appear favorable, thereby reducing operation time and WIT. The present results suggest that the device may represent an alternative to parenchyma suturing in LPN.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Erne E, Kruck S, Todenhoefer T, et al. Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy. Surg Endosc. 2021. PMID: 33591449. doi:10.1007/s00464-021-08333-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。